AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Genentech (ACTEMRA) (actemra.com)
This is a benchmark for low-BS communication in a highly regulated industry. The site prioritizes safety, technical protocol, and regulatory compliance over all marketing objectives, resulting in an exceptionally low score of 9. It provides maximum substance with minimal semantic drift.
Integrate specific ClinicalTrials.gov identifiers (NCT numbers) directly into the clinical results headings for instant external verification. Add outbound peer-reviewed study citations to the body text to increase the verified proof_links_count. Implement Person schema for the Chief Medical Officer to provide a human face to the corporate authority. Include specific patent status or expiration years to fulfill intellectual property proof expectations.
Information density is extremely high, with a near-zero ratio of marketing power words to technical substance. Text includes specific chemical designations like interleukin-6 (IL-6) receptor antagonist and precise clinical instructions such as 162 mg subcutaneous injection once weekly. Points were only added for the mandatory repetition of Important Safety Information across all four pages, which is a regulatory requirement rather than standard marketing fluff.
AI does not see your layout — it sees your DOM. Get a Clinical Semantic Structure Diagnosis to reveal how your page is segmented, weighted, and interpreted.
There is zero semantic drift across the analyzed pages. The homepage meta-signal promising information on RA, GCA, and SSc-ILD is met with granular, dedicated sub-pages that provide specific treatment protocols and clinical context for each condition. The H2 structures are consistent and logical, ensuring a patient or professional finds exactly what the hero section promised.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
Trust theatre is absent as the site avoids generic testimonials and fake reviews; the review_count is 0 across all pages. While the proof_links_count in the metadata is 0, the body text provides clear paths to substance through mentions of full Prescribing Information and clinical study results. A minor penalty was applied for performance claims that refer to clinical results without providing direct external outbound links in the provided data set.
Proof density is high, with a ratio of approximately one technical specification or safety warning for every sentence of descriptive text. The site provides specific instructions for use, such as transitioning between IV and SC administration and weight-based dosing schedules (6 mg/kg IV), which serve as high-utility evidence for the target audience.
To see how the methodology translates into real diagnostic output, review a full executive level analysis applied to a global fashion retailer. View the Mango Executive SEO Strategy for a concrete example of how structural gaps, semantic weaknesses, and conversion friction are surfaced in practice.
The site uses a standard pharmaceutical layout, which is highly commoditized but functionally necessary. Clichés from the industry dictionary such as FDA approved and mechanism of action are used as technical descriptors rather than empty buzzwords. The value proposition is entirely unique to the specific molecule, making it impossible to copy-paste onto a competitor site.
Authority is solidly established through Genentech’s Organization schema, which includes address, contact points, and a clear description of the entity. There are no gaps in authority as the brand is a known subsidiary of Roche, though a technical Person schema for lead researchers or medical directors is missing from the provided structured data.
There is no disconnect between marketing tone and clinical reality. Every claim regarding the treatment of RA, GCA, or COVID-19 is immediately followed by contraindications, side effects, and monitoring requirements. This ‘fair balance’ approach is the antithesis of business bullshit.
Medical Devices, Pharma & Biotech BS: Genentech (ACTEMRA) (actemra.com)
The content perfectly aligns with the Pharma and Biotech industry, focusing on a specific therapeutic agent, tocilizumab. It adheres to strict regulatory communication standards, including indications for use and comprehensive safety warnings.
Every retrieval failure begins with one root cause: the model cannot segment the page correctly. Read the Semantic HTML Technical Guide to learn how structural clarity prevents chunk collapse and embedding noise.
“The score of 9 is driven primarily by minor penalties for repetitive legal headers and a lack of external proof links in the metadata, despite the body text being highly substantive. Pillars for Semantic Coherence and Identity and Authority scored 0, indicating a perfectly aligned and verified digital presence. This represents a site that backs almost every claim with substance.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 29, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Genentech (ACTEMRA) to view the most current version of their content and see directly what the company offers.